Response assessment using <sup>68</sup>Ga-PSMA ligand PET in patients undergoing <sup>177</sup>Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.

Eur J Nucl Med Mol Imaging · 2019 · PMC6451716 · PMID 30569186

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Nevertheless, these results did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.